133
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Molecular Mechanism of Salvia miltiorrhiza in the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking Technology

&
Pages 425-441 | Received 28 Oct 2023, Accepted 01 Feb 2024, Published online: 12 Feb 2024

References

  • Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. PMID: 31631858. doi:10.1016/s0140-6736(19)32319-0
  • Brody H. Colorectal cancer. Nature. 2015;521(7551):S1. PMID: 25970450. doi:10.1038/521S1a
  • Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. PMID: 26818619. doi:10.1136/gutjnl-2015-310912
  • Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–732. PMID: 31455888. doi:10.1038/s41575-019-0189-8
  • Lee RM, Cardona K, Russell MC. Historical perspective: two decades of progress in treating metastatic colorectal cancer. J Surg Oncol. 2019;119(5):549–563. PMID: 30806493. doi:10.1002/jso.25431
  • van der Stok EP, Spaander MCW, Grunhagen DJ, Verhoef C, Kuipers EJ. Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol. 2017;14(5):297–315. PMID: 27995949. doi:10.1038/nrclinonc.2016.199
  • McQuade RM, Stojanovska V, Bornstein JC, Nurgali K. Colorectal cancer chemotherapy: the evolution of treatment and new approaches. Curr Med Chem. 2017;24(15):1537–1557. PMID: 28079003. doi:10.2174/0929867324666170111152436
  • Morris EJ, Sandin F, Lambert PC, et al. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut. 2011;60(8):1087–1093. PMID: 21303917. doi:10.1136/gut.2010.229575
  • Dueland S, Yaqub S, Syversveen T, et al. Survival outcomes after portal vein embolization and liver resection compared with liver transplant for patients with extensive colorectal cancer liver metastases. JAMA Surg. 2021;156(6):550–557. PMID: 33787838; PMCID: PMCPMC8014205. doi:10.1001/jamasurg.2021.0267
  • Zhao H, He M, Zhang M, et al. Colorectal cancer, gut microbiota and traditional Chinese medicine: a systematic review. Am J Chin Med. 2021;49(4):805–828. PMID: 33827382. doi:10.1142/s0192415x21500385
  • Jiang HZ, Jiang YL, Yang B, Long FX, Yang Z, Tang DX. Traditional Chinese medicines and capecitabine-based chemotherapy for colorectal cancer treatment: a meta-analysis. Cancer Med. 2023;12(1):236–255. PMID: 35650714; PMCID: PMCPMC9844598. doi:10.1002/cam4.4896
  • Liu S, Wang Y, Shi M, et al. SmbHLH60 and SmMYC2 antagonistically regulate phenolic acids and anthocyanins biosynthesis in Salvia miltiorrhiza. J Adv Res. 2022;42:205–219. PMID: 36513414; PMCID: PMCPMC9788942. doi:10.1016/j.jare.2022.02.005
  • Su CY, Ming QL, Rahman K, Han T, Qin LP. Salvia miltiorrhiza: traditional medicinal uses, chemistry, and pharmacology. Chin J Nat Med. 2015;13(3):163–182. PMID: 25835361. doi:10.1016/s1875-5364(15)30002-9
  • Chen X, Guo J, Bao J, Lu J, Wang Y. The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review. Med Res Rev. 2014;34(4):768–794. PMID: 24123144. doi:10.1002/med.21304
  • Lyu J, Xue M, Li J, et al. Clinical effectiveness and safety of salvia miltiorrhiza depside salt combined with aspirin in patients with stable angina pectoris: a multicenter, pragmatic, randomized controlled trial. Phytomedicine. 2021;81:153419. PMID: 33360345. doi:10.1016/j.phymed.2020.153419
  • Xu G, Zhao W, Zhou Z, Zhang R, Zhu W, Liu X. Danshen extracts decrease blood C reactive protein and prevent ischemic stroke recurrence: a controlled pilot study. Phytother Res. 2009;23(12):1721–1725. PMID: 19449344. doi:10.1002/ptr.2819
  • Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, Schmidt H. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 2022;43(2):136–150. PMID: 34895945. doi:10.1016/j.tips.2021.11.004
  • Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682–690. PMID: 18936753. doi:10.1038/nchembio.118
  • Pinzi L, Rastelli G. Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci. 2019;20(18):4331. PMID: 31487867; PMCID: PMCPMC6769923. doi:10.3390/ijms20184331
  • Crampon K, Giorkallos A, Deldossi M, Baud S, Steffenel LA. Machine-learning methods for ligand-protein molecular docking. Drug Discov Today. 2022;27(1):151–164. PMID: 34560276. doi:10.1016/j.drudis.2021.09.007
  • Chen J, Elfiky A, Han M, Chen C, Saif MW. The role of Src in colon cancer and its therapeutic implications. Clin Colorectal Cancer. 2014;13(1):5–13. PMID: 24361441. doi:10.1016/j.clcc.2013.10.003
  • Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28(3):187–196. PMID: 16129903. doi:10.1385/criai:28:3:187
  • Slattery ML, Murtaugh M, Caan B, Ma KN, Neuhausen S, Samowitz W. Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer. 2005;115(1):148–154. PMID: 15688407. doi:10.1002/ijc.20843
  • Jin W. Regulation of Src family kinases during colorectal cancer development and its clinical implications. Cancers. 2020;12(5):1339. PubMed PMID: 32456226; PMCID: PMCPMC7281431. doi:10.3390/cancers12051339
  • Lin CM, Chen YH, Ma HP, et al. Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro. J Agric Food Chem. 2012;60(51):12451–12457. PMID: 23210512. doi:10.1021/jf300964f
  • Lu CC, Chu PY, Hsia SM, Wu CH, Tung YT, Yen GC. Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells. Int J Oncol. 2017;50(2):736–744. PMID: 28101572. doi:10.3892/ijo.2017.3844
  • Luo TT, Lu Y, Yan SK, Xiao X, Rong XL, Guo J. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective. Chin J Integr Med. 2020;26(1):72–80. PMID: 30941682. doi:10.1007/s11655-019-3064-0
  • Zhao L, Zhang H, Li N, et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023;309:116306. PMID: 36858276. doi:10.1016/j.jep.2023.116306
  • Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–685. PMID: 33591350. doi:10.1001/jama.2021.0106
  • Zhao H, Han B, Li X, et al. Salvia miltiorrhiza in breast cancer treatment: a review of its phytochemistry, derivatives, nanoparticles, and potential mechanisms. Front Pharmacol. 2022;13:872085. PMID: 35600860; PMCID: PMCPMC9117704. doi:10.3389/fphar.2022.872085
  • Bae WJ, Choi JB, Kim KS, et al. Inhibition of proliferation of prostate cancer cell line DU-145 in vitro and in vivo using Salvia miltiorrhiza bunge. Chin J Integr Med. 2020;26(7):533–538. PMID: 28337641. doi:10.1007/s11655-017-2801-5
  • Ye YT, Zhong W, Sun P, et al. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway. J Ethnopharmacol. 2017;200:107–116. PMID: 28088493. doi:10.1016/j.jep.2016.12.051
  • Liu X, Yang Y, Zhang X, et al. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell. J Gastroenterol Hepatol. 2010;25(2):420–426. PMID: 19793165. doi:10.1111/j.1440-1746.2009.05981.x
  • Zhou J, Jiang YY, Chen H, Wu YC, Zhang L. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Cell Proliferation. 2020;53(2):e12739. PMID: 31820522; PMCID: PMCPMC7046305. doi:10.1111/cpr.12739
  • Chen L, Yang Q, Zhang H, et al. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway. J Ethnopharmacol. 2020;260:113066. PMID: 32505837. doi:10.1016/j.jep.2020.113066
  • Huang X, Vaag A, Hansson M, Groop L. Down-regulation of insulin receptor substrates (IRS)-1 and IRS-2 and Src homologous and collagen-like protein Shc gene expression by insulin in skeletal muscle is not associated with insulin resistance or type 2 diabetes. J Clin Endocrinol Metab. 2002;87(1):255–259. PMID: 11788655. doi:10.1210/jcem.87.1.8144
  • Krogh-Madsen R, Plomgaard P, Keller P, Keller C, Pedersen BK. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue. Am J Physiol Endocrinol Metab. 2004;286(2):E234–E238. PMID: 14532168. doi:10.1152/ajpendo.00274.2003
  • Huang YH, Yang HY, Hsu YF, Chiu PT, Ou G, Hsu MJ. Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells. Angiogenesis. 2014;17(2):407–418. PMID: 24048742. doi:10.1007/s10456-013-9386-1